Sorrento Therape
Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, provides therapeutic solutions in the United States and internationally. It offers chimeric antigen receptor T-cell therapy, dimeric antigen receptor T-cell therapy, and antibody-drug conjugates, as well as Seprehvec, SOFUSA, RTX, and SEMDEXA. The company also develops antiviral therapies and vaccines, includi… Read more
Sorrento Therape (SRNE) - Total Assets
Latest total assets as of June 2023: $456.69 Million USD
Based on the latest financial reports, Sorrento Therape (SRNE) holds total assets worth $456.69 Million USD as of June 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sorrento Therape - Total Assets Trend (2007–2022)
This chart illustrates how Sorrento Therape’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sorrento Therape - Asset Composition Analysis
Current Asset Composition (December 2022)
Sorrento Therape's total assets of $456.69 Million consist of 20.4% current assets and 79.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.0% |
| Accounts Receivable | $24.47 Million | 5.2% |
| Inventory | $9.98 Million | 2.1% |
| Property, Plant & Equipment | $51.97 Million | 11.0% |
| Intangible Assets | $136.90 Million | 29.0% |
| Goodwill | $80.27 Million | 17.0% |
Asset Composition Trend (2007–2022)
This chart illustrates how Sorrento Therape's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sorrento Therape's current assets represent 20.4% of total assets in 2022, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2022, down from 100.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, an increase from 0.0% in 2007.
- Asset Diversification: The largest asset category is intangible assets at 29.0% of total assets.
Sorrento Therape Competitors by Total Assets
Key competitors of Sorrento Therape based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Sorrento Therape - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Sorrento Therape generates 0.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Sorrento Therape is currently not profitable relative to its asset base.
Sorrento Therape - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.50 | 1.35 | 1.76 |
| Quick Ratio | 0.47 | 1.21 | 1.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-131.84 Million | $ 50.73 Million | $ 62.84 Million |
Sorrento Therape - Advanced Valuation Insights
This section examines the relationship between Sorrento Therape's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.01 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -31.9% |
| Total Assets | $472.84 Million |
| Market Capitalization | $539.11K USD |
Valuation Analysis
Below Book Valuation: The market values Sorrento Therape's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Sorrento Therape's assets decreased by 31.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sorrento Therape (2007–2022)
The table below shows the annual total assets of Sorrento Therape from 2007 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $472.84 Million | -31.95% |
| 2021-12-31 | $694.82 Million | +29.67% |
| 2020-12-31 | $535.82 Million | -3.91% |
| 2019-12-31 | $557.63 Million | -10.65% |
| 2018-12-31 | $624.09 Million | +44.59% |
| 2017-12-31 | $431.61 Million | +7.48% |
| 2016-12-31 | $401.59 Million | +16.90% |
| 2015-12-31 | $343.52 Million | +142.70% |
| 2014-12-31 | $141.54 Million | +52.88% |
| 2013-12-31 | $92.58 Million | +1265.19% |
| 2012-12-31 | $6.78 Million | +48.43% |
| 2011-12-31 | $4.57 Million | -19.67% |
| 2010-12-31 | $5.69 Million | +60.05% |
| 2009-12-31 | $3.55 Million | +800.78% |
| 2008-12-31 | $394.52K | +1703.21% |
| 2007-12-31 | $21.88K | -- |